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Abstract
Background: Genomic copy number variants (CNVs) involving >1 kb of DNA have recently been found to be widely
distributed throughout the human genome. They represent a newly recognized form of DNA variation in normal
populations, discovered through screening of the human genome using high-throughput and high resolution methods
such as array comparative genomic hybridization (array-CGH). In order to understand their potential significance and to
facilitate interpretation of array-CGH findings in constitutional disorders and cancers, we studied 27 normal individuals
(9 Caucasian; 9 African American; 9 Hispanic) using commercially available 1 Mb resolution BAC array (Spectral
Genomics). A selection of CNVs was further analyzed by FISH and real-time quantitative PCR (RT-qPCR).
Results: A total of 42 different CNVs were detected in 27 normal subjects. Sixteen (38%) were not previously reported.
Thirteen of the 42 CNVs (31%) contained 28 genes listed in OMIM. FISH analysis of 6 CNVs (4 previously reported and
2 novel CNVs) in normal subjects resulted in the confirmation of copy number changes for 1 of 2 novel CNVs and 2 of
4 known CNVs. Three CNVs tested by FISH were further validated by RT-qPCR and comparable data were obtained.
This included the lack of copy number change by both RT-qPCR and FISH for clone RP11-100C24, one of the most
common known copy number variants, as well as confirmation of deletions for clones RP11-89M16 and RP5-1011O17.
Conclusion: We have described 16 novel CNVs in 27 individuals. Further study of a small selection of CNVs indicated
concordant and discordant array vs. FISH/RT-qPCR results. Although a large number of CNVs has been reported to date,
quantification using independent methods and detailed cellular and/or molecular assessment has been performed on a
very small number of CNVs. This information is, however, very much needed as it is currently common practice to
consider CNVs reported in normal subjects as benign changes when detected in individuals affected with a variety of
developmental disorders.
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Background
There is considerable genomic variability among humans
that is not associated with a recognizable clinical pheno-
type. This variability is evident at both the chromosomal
level (as microscopically visible gains or losses of chromo-
somal bands or regions) [1] and at the single nucleotide
level (as single nucleotide polymorphisms (SNPs)) [2].
The gains and losses of sub-microscopic DNA segments
larger than 1 kb are termed copy number variants (CNVs)
[3]. They represent a newly recognized class of DNA vari-
ation, identified as a result of the introduction of compar-
ative genomic hybridization (CGH) array technology that
enables the study of variation in the number of copies of
specific DNA segments among individuals [4,5]. The
widespread presence of CNVs in normal individuals has
now been documented using not only array CGH-con-
taining BAC clones [6,7] but also oligonucleotide arrays at
high resolution as well SNP data analysis [8-12] and DNA
sequence comparisons between individuals [13].
The discovery of CNVs presents investigators with a
number of challenges as CNVs complicate the interpreta-
tion of array data and efforts to attribute microdeletions
and microduplications identified in individuals with con-
stitutional disorders or in cancerous tissues to the disease
processes. The role of CNVs in causing or influencing the
susceptibility to disease and genome evolution remains
largely unknown. A catalogue of published CNVs can be
found in the public database [14], and helps to guide the
interpretation of array CGH findings. However, the
number and identity of polymorphic loci detected in dif-
ferent studies varies considerably [15], likely because of
differences across various array platforms, analytical
methods and the populations investigated. In addition,
copy number differences for many of the CNVs listed in
the above database are not confirmed using secondary
independent quantification methods (FISH or quantita-
tive DNA methods). Therefore, further work to identify
and characterize CNVs in human populations and con-
firm copy number variability is essential in order to better
understand the significance of CNVs and to determine
their role in common disorders.
We studied 27 phenotypically normal individuals and
detected 42 different sub-microscopic CNVs using the 1
Mb resolution whole genome array-CGH. We used real-
time quantitative PCR (RT-qPCR) and FISH to confirm
CNVs. The results of these studies are presented.
Results
1. Array-CGH findings of CNVs in normal subjects
By studying 27 phenotypically normal, healthy individu-
als (17 females and 10 males; 9 African-American, 9 His-
panic and 9 Caucasian) using commercial array-CGH
(Spectral Genomics), 42 different CNVs were identified
and further classified into 2 subgroups. Group A contains
26 CNVs which were previously reported in the public
database [14], either as an identical clone entry or as part
of a reported genomic CNV region. The remaining 16
CNVs in Group B of Table 1 represent novel CNVs. In
total, 8 CNVs were observed in two or more individuals;
the majority of recurrent CNVs (7/8) belonged to group A.
Segmental duplications were found in 8 CNVs (6 in
Group A and 2 in Group B). Of the 42 CNVs, only 13 were
found to contain genes (N = 28) listed in the OMIM data-
base; 9/28 genes were found in one CNV in Group A
(RP11-144O23 mapping to 12p13.2). In addition to
genes primarily involved in functions of the human
immune or sensory systems, signal transduction and
metabolism, genes involved in transcription regulation,
neurotransmitter transport, cell proliferation and differ-
entiation or development were also identified (Table 1).
The three clones which showed copy number changes
most frequently in our subjects were RP11-259N12
(1p13.3), RP11-100C24 (13q21) and RP11-79F15
(19p13.2), and were found in 5, 9 and 5 individuals
respectively.
2. FISH and RT-qPCR analysis of polymorphic clones
a) FISH
In order to establish the cellular copy number pattern of
known and novel CNVs, we performed FISH analysis of 6
CNVs (Table 2) in subjects for whom a cell pellet was
available. For some clones, copy number changes could
be confirmed by FISH, while for others the FISH patterns
were discordant with array-CGH results. For example,
array analysis of clones RP5-1011O17 at 2q37.3 and
RP11-89M16 at 8p22 both showed a deletion upon array
analysis, and both were subsequently confirmed by FISH.
However, the FISH signal pattern was different for these
two clones: clone RP5-1011O17 had a complete loss of
one copy, demonstrating a complete deletion while clone
RP11-89M16 exhibited a diminished FISH signal on one
of the homologs suggestive of a partial deletion (Figure 1).
Conversely, FISH analysis of clone RP11-100C24
(13q21.1) showed consistent normal signal patterns (2
copies/cell) in multiple subjects regardless of whether the
clone was seen as a loss (Figure 2) or gain (Figure 3) on
array analysis. Gains of clones RP11-125A5 and RP11-
270M20 could not be confirmed by FISH (Table 2).
Finally, gain of the clone RP11-598F7 was seen as multi-
ple signals mapping to several chromosomes, demon-
strating the presence of homologous sequences within
this clone in several regions of the genome (Figure 4). This
observation was also confirmed by the in silico eFISH sim-
ulation tool [16].BMC Genomics 2007, 8:167 http://www.biomedcentral.com/1471-2164/8/167
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Table 1: Previously reported (A) and novel (B) CNVs
Number Cytoband Clone 
Name
Position 
(Mb)
Ethnic 
origin
Duplication Deletion Overlap 
with 
segmental 
duplications
Genes on 
OMIM list
Biological process
Group A 1 1p36.13 RP1-163M9* 16.1 AA 1 Yes
2 1p13.3 RP11-
259N12
103.4 2C, AA, 2H 3 2 Yes AMY2A, 
AMY1A, 
AMY1B, 
AMY1C
Glycogen 
metabolism
3 1q42.13 RP5-
1016N21
229.7 C, H 2 No
4 2p12 RP11-
345F13
82.8 AA 1 No
5 2qter RP5-
1011O17
242.9 C, 2H 3 Yes
6 3q26.3 RP11-114M1 178.8 H 1 No
7 4q25 RP11-18D18 112.7 H 1 No
8 6pter AL035696.1
4
0.1 H 1 Yes
9 6q12 RP11-80L16 67 AA 1 No
10 6q24.1 RP1-69B13 146.7 H 1 No GRM1 G-protein mediated 
signaling, neuronal 
activities
11 7pter RP1-164D18 0.1 AA 1 No
12 7p21.1 IIID11 18.8 C 1 No
13 8p22 RP11-89M16 17.2 C 1 No SLC7A2, 
PDGFRL
Amino acid 
transport, receptor 
protein tyrosine 
kinase signaling 
pathway
14 10qter CTC-
261B16
135.2 AA 1 No
15 11q22.3 RP11-179B7 104.4 AA 1 No
16 12p13.2 RP11-
144O23
10.9 H 1 No TAS2R7, 
TAS2R8, 
TAS2R9, 
TAS2R10, 
PRR4, PRH1, 
TAS2R13, 
PRH2, 
TAS2R14
Taste receptor 
activity, visual 
perception, cell 
adhesion-mediated 
signaling, immunity 
and defense
17 13q21.1 RP11-
100C24
56.7 4C, AA, 4H 5 4 No
18 14q12 RP11-125A5 27.6 C, 3H 2 2 No
19 15q11.2 RP11-80H14 20.4 H 1 No CYFIP1 Signal transduction, 
developmental 
processes
20 16p11.2 RP11-499D5 
*
33.8 H 1 YesBMC Genomics 2007, 8:167 http://www.biomedcentral.com/1471-2164/8/167
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21 16p11.2 RP11-488I20 
*
35.6 H 1 No
22 16p11.1 RP11-80F22 
*
35.7 C, 2H 3 No
23 17pter CTB-68F18 0.1 C 1 No RPH3AL Synaptic transmission
24 17q24.3 RP11-
300G13
68.6 H 1 No KCNJ16, 
KCNJ2
Cation transport, 
muscle contraction
25 19p13.2 RP11-79F15 8.8 C, 2AA, 2H 1 4 Yes MBD3L1, 
MUC16
mRNA transcription
26 19qter 1129-c9 76 C 1 No
Group B 1 2q14.3 RP11-
270M20
125.3 C 1 No CNTNAP5 Cell adhension-
mediated signaling, 
synaptic transmission
2 4q28.1 RP11-77P11 128.2 H 1 No
3 4q31.2 RP11-89E4 145.8 H 1 No
4 6p24 RP1-103M22 9.5 H 1 No
5 7q33 RP11-140I14 134.6 AA 1 No CNOT4 mRNA transcription 
regulation
6 10p12.3 RP11-91D9 19.7 H 1 No
7 12pter RP11-598F7 
*
0 C 1 No SLC6A12 neurotransmitter 
transport
8 13q13.1 RP11-87G1 33 AA 1 No
9 19q13.43 F21283 63.7 H 1 No MZF1 regulation of 
transcription
10 Xpter LLNOYCO3
M11D2
03 C ,  A A2 2 N o
11 Xp11.3 RP11-
252K10
41.7 H 1 No
12 Xp11.21 RP11-266I3 
*
53.7 AA 1 Yes
13 Xp11.1 ICRFC100G
11100
56.1 C 1 No
14 Xq21.1 RP11-
192B18
84.4 H 1 No
15 Xq26.2 CTB-45B24 131.4 H 1 No PCYT1B, 
PHF6
Regulation of 
metabolism and 
transcription, ovarian 
follicle development, 
spermatogenesis
16 Yq11.2 RP11-91A13 
*
17.7 AA 1 Yes
Note: * Clone showing multiple sites based on e-FISH.
AA: African American; H: Hispanic; C: Caucasian.
Table 1: Previously reported (A) and novel (B) CNVs (Continued)BMC Genomics 2007, 8:167 http://www.biomedcentral.com/1471-2164/8/167
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b) RT-qPCR and FISH comparisons
RT-qPCR analysis was performed for 3/6 clones tested by
FISH in order to confirm the array results and to help
resolve the array and FISH discrepancies (Table 2). Com-
parable results between FISH and RT-qPCR were obtained
for all 3 clones tested by both methods – i.e. deletions of
RP11-89M16 and PR5-1011O17 were confirmed by RT-
qPCR and the lack of copy number change (both gain and
loss) for RP11-100C24 as seen by FISH was also noted by
RT-qPCR.
Discussion
Our study of 27 normal subjects revealed a total of 42
CNVs: 26 previously described CNVs [14] and 16 (38%)
novel CNVs. A higher number of known than novel CNVs
showed recurrence in the subjects tested (7/8 recurrent
clones were previously described -Table 1). Similarly, evi-
dence of segmental duplications was found in 6/8 previ-
ously described CNVs. This confirms the observation that
recurring CNVs are more prevalent in the human popula-
tion, and tend to be associated with segmental duplica-
tions [7], while our novel CNVs are possibly less frequent
and individual specific.
The number of CNVs detected in our controls is compara-
ble to the number obtained by other investigators using
the same commercial array-CGH and cut-off levels [17-
19]. However, the number is significantly smaller than
that observed by Iafrate et al [6] who reported 255 CNVs
in 59 individuals. Although they used the same array-
Table 2: List of polymorphic BAC clones used for FISH/qPCR analysis in controls.
Cytoband Clone name Previously 
reported
Size (kb) Gene(s) 
contained
Overlap with 
segmental 
duplications
ARRAY FISH qPCR
2q37.3 RP5-1011O17 Y 21.8 No yes deletion complete loss of one copy (Fig1) C
13q21.1 RP11-100C24 Y 129.3 No No gain 2 copies (Fig3) NC
loss 2 copies (Fig2) NC
14q12 RP11-125A5 Y 186.5 No No gain/loss 2 copies (not shown) NT
2q14.3 RP11-270M20 N 140.4 No No gain 2 copies (not shown) NT
8p22 RP11-89M16 Y 176 MTMR7; 
SLC7A2; 
PDGFRL
No deletion partial deletion of one copy (Fig 1) C
12p13.33 RP11-598F7 N 0.5 SLC6A12 No gain multiple sites on non-homologous 
chromosomes (Fig 4)
NT
C = confirmed
NC = not confirmed
NT = not tested
FISH confirmation of deletions detected by array-CGH Figure 1
FISH confirmation of deletions detected by array-CGH. i. Deletion of clone RP5-1011O17 (2q27.3) as demonstrated 
by a single signal in both metaphase chromosomes (arrowhead) (i) and interphase cells (ii). Partial deletion of clone RP11-
89M16 (8p22) is seen as a diminished signal on one of the homologues (iii). A control probe at 8qter, RP11-17M8, was used to 
eliminate difference in signal intensities due to artifacts. One of the signals on 8p22 was consistently smaller (arrow) than any of 
the 3 remaining signals on the two chromosome 8 homologues.BMC Genomics 2007, 8:167 http://www.biomedcentral.com/1471-2164/8/167
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CGH platform, a different dynamic website-based analyt-
ical method was applied, instead of our fixed cut-off levels
of 1.2 for duplications and 0.8 for deletions, suggesting
that the analytical method used plays a significant role in
the number of apparent CNVs detected among individu-
als. Recently, a number of studies addressed the question
of global genomic variation using different approaches
including tiling BAC array [7,12,20], SNP polymorphisms
and oligo arrays [9-11]. The number of CNVs and chro-
mosomal regions affected varied among studies even
when the same array platform was used. For example, the
BAC tiling arrays detected 3654 autosomal segmental
CNVs in 95 controls [7], 913 CNVs in 270 controls [12]
and 258 CNVs in 100 individuals with intellectual disabil-
ity and their phenotypically normal parents [20]. The dif-
ferences in the populations studied may have contributed
to the observed discrepancies, however, even when the
same individuals were examined using a different
approach (BAC array vs. SNPs) less than half (43%) of the
CNVs were detected on both platforms [12]. It is now evi-
dent that none of the existing technologies can capture all
human variation.
One of the pre-requisites for understanding global human
variation is the confirmation of CNVs using alternative
methods. Their recurrence and presence as detected using
different platforms supports that these are true differences
among individuals. However, a large number of CNVs are
still "unique", i.e. specific for a control subject/family or
study. Independent quantification methods such as FISH
Array and FISH analysis of BAC clone RP11-100C24 (loss) Figure 2
Array and FISH analysis of BAC clone RP11-100C24 (loss). (i) The array detected deletion of RP11-100C24 could not 
be confirmed in interphase (ii) and metaphase cells by FISH (iii). The details of profile interpretation are described in Tyson et 
al [26]. Briefly, deletion of a clone was considered if the red and the blue array profiles show separation for that clone and the 
red profile is above the line corresponding to the value of 1. On the other hand, if the blue array profile is above the line cor-
responding to the value of 1, a gain for the clone is considered.BMC Genomics 2007, 8:167 http://www.biomedcentral.com/1471-2164/8/167
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or RT-qPCR should ideally be performed on many CNVs,
particularly those appearing in one individual, as these are
the most likely ones to be false positives [7]. Considering
the large number of CNVs reported (>6000 entries in the
database of human variation) the number of validated
CNVs using independent quantification methods such as
RT-qPCR or FISH is still proportionally very small due to
the time consuming or limited throughput of single locus
analysis. For example, in two recent larger studies report-
ing a total of >5000 CNVs, less than 300 CNVs were vali-
Array and FISH analysis of BAC clone RP11-100C24 (gain) Figure 3
Array and FISH analysis of BAC clone RP11-100C24 (gain). (i) The array detected gain of RP11-100C24 could not be 
confirmed in interphase (ii) and metaphase cells by FISH (iii).
Duplication of clone RP11-598F7 in a normal subject Figure 4
Duplication of clone RP11-598F7 in a normal subject. Gain of a terminal clone from 12p on the array is indicated with 
an arrow (i). FISH probe for this clone hybridizes to multiple non-homologous chromosomes (chromosome 12-arrow; chro-
mosome 20-arrowhead, ii)BMC Genomics 2007, 8:167 http://www.biomedcentral.com/1471-2164/8/167
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dated using quantification methods [7,12]. Using FISH
we have confirmed array-detected copy number changes
of 3/6 selected CNVs (Table 2), while for 3/6 CNVs a nor-
mal two signal FISH pattern was seen. We tested two
FISH-confirmed CNVs using RT-qPCR, one partially and
one fully deleted (RP11-89M16 and RP5-1011O17,
respectively), and observed concordance between all 3
methods (array-CGH, FISH and RT-qPCR). As two of the
three FISH non-confirmed CNVs (RP11-125A5 and RP11-
100C24) are recognized as being very common and recur-
rent on multiple platforms [6,12], we further evaluated
RP11-100C24 using RT-qPCR but failed to achieve confir-
mation of both gain and loss. It is possible that this CNV
is composed of tightly packed repeats which can be dis-
cerned only by fiber FISH, as noted for clone RP11-
259N12 from chromosome 1 [6]. Additional cause of the
array-CGH vs. FISH/RT-qPCR discrepancy may be due to
the fact that array-CGH assays evaluate the relative ratio of
segmental DNA copy number in the test DNA vs. refer-
ence DNA, and do not provide an absolute number of
copies, as explained in Figure 5.
The information on new CNVs is expanding dramatically,
and cataloguing clones for which independent quantifica-
Correlation of FISH patterns with array detected copy number variability Figure 5
Correlation of FISH patterns with array detected copy number variability. The discordant results between the array 
and FISH/RT-qPCR findings may be due to the fact that array CGH uses the relative ratio of segmental DNA copy number in 
the test DNA and the reference DNA, the latter being a pool of genomic DNA from several different normal individuals. The 
copy number of a specific clone in the reference DNA pool determines the outcome of an array analysis (typical gain (i) and 
loss (ii) on the array and FISH are shown in Figure 5A). For clones with a very variable copy number, a loss on the array may 
simply be the result of fewer copies in the test individual compared to the pool of reference DNA (Figure 5B), and if the 
number of copies in the test individual is 2, confirmation by any of the methods (FISH or qPCR) may not be possible. Con-
versely, the gain on the array is the result of the presence of more copies of the specific DNA segment in the test DNA com-
pared to the reference (Figure 5C). If the gain occurred as a tandem duplication (or multiplication) of the DNA segment, its 
detection may not be possible by FISH due to limited resolution. Alternatively, if the gain involved only some sections of the 
DNA segment, then it may not be detectable by RT-qPCR as typically only a small number of short sequences within non-
repeated DNA segments within each region are used for analysis.BMC Genomics 2007, 8:167 http://www.biomedcentral.com/1471-2164/8/167
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tion is performed are desirable, as only detailed analysis
of a large number of CNVs will help better understand
their basic structure, DNA content and reasons for varia-
bility. Currently, the significance of CNVs remains puz-
zling, as many of these genomic regions contain genes and
coding sequences associated with known genetic disor-
ders [6,8,21]. In our subjects 13/42 different CNVs were
associated with OMIM genes; the number was usually not
higher than 2 genes/CNV, except for CNV RP11-144O23
which had 9 genes involved in sensory perception, cell
adhesion-mediated signaling, immune and defense proc-
esses (Table 1A). This clone was noted in one of our His-
panic individuals and was reported as one of the more
divergent clones in the 4 populations reported by Redon
et al [12]. Many of the genes in CNVs are described as
"environmental sensor genes" and are associated with
mechanisms mediating immune responsiveness
(defensin, interferon regulatory factor 4, etc.), cellular
metabolism (cytochrome P450 genes and carboxyesterase
gene families), and membrane surface interactions (Rhe-
sus blood group gene families, melanoma antigen gene).
It is now established that the copy number variability of
some genes can influence susceptibility to some diseases
[22,23]. For example, it has been reported that people
with fewer copy numbers of CCL3L1, a gene involved in
immunity, are more susceptible to HIV infection [22]. The
extent of associations of CNVs with disease susceptibility
will become clearer as we learn more about the distribu-
tion of well characterized CNVs in individuals whose
health and medical histories are fully evaluated.
Conclusion
Submicroscopic CNVs are a common form of human
genomic variation, which can be readily identified by
array-CGH technology in phenotypically normal individ-
uals. The number of CNVs detected in each study is influ-
enced by several factors, especially the array platform and
method of analysis. Our results confirm the wide distribu-
tion of CNVs in three different ethnic populations and
expand the number of recognized CNVs. Cataloguing of
confirmed CNVs, quantified using independent methods,
would facilitate their interpretation and understanding of
their significance in the future.
Methods
Subjects
Normal controls: A total of 27 normal individuals were
studied. Nine Caucasian volunteers were recruited for the
study and their DNA extracted and chromosomes
obtained using routine methodology. Eighteen previously
banked DNA samples from African-American and His-
panic individuals were also examined. All samples were
anonymized for all personal identifiers.
Array CGH
Array-CGH methods were performed as previously
described [24]. Briefly, we used the commercially availa-
ble genomic DNA array comprising 2,600 BAC clones
with an average of 1 Mb resolution throughout the human
genome (Spectral Genomics™, Houston, TX). The list of
clones on this array can be obtained from website [25].
Genomic DNA from the tested subjects was extracted from
peripheral venous blood using Puregene DNA Isolation
Kit (Gentra Systems Inc., Minneapolis, MN, USA) accord-
ing to the manufacturer's protocol. The reference DNA
was purchased from Promega and represents a pool of
genomic DNA from four normal control samples. Both
forward (test DNA labeled with Cy3, reference DNA
labeled with Cy5) and reverse labeling experiments (test
DNA labeled with Cy5, reference DNA labeled with Cy3)
were performed for each patient. Following hybridization,
slides were scanned on a GENEPIX 4000B scanner (Axon
Instruments, Union City, CA) and the 16-bit TIFF images
captured using GENEPIX Pro 4.0 software. The images
were analyzed using SPECTRALWARE TM BAC Array
Analysis Software v2.0 (Spectral Genomics) as described
previously [24]. In all cases except one, the test and refer-
ence DNA were sex matched. For the sex unmatched case,
the clones on the X and Y chromosome were not consid-
ered. We have used cut-off values of 1.2 for gain and 0.8
for loss as determined previously by ourselves and others
[17-19,24]. In addition, we performed one self hybridiza-
Table 3: Primers used in RT-qPCR.
Cytoband Clone name Primer name Forward primer (5'-3') Reverse Primer (5'-3')
2q37.3 RP5-1011O17 RP5-1011O17-A
RP5-1011O17-B
RP5-1011O17-C
AAATGGTGACTCTTGTGAATTTGGT
GGGAAGGTGGGTGGCTACA
ACACTGATGAAGGTTTTCCTTGTG
GGGAAGCTGTGGCCAAAA
CAAGCAGGCCTTGGTAACACA
GGCAGCACTGAACTACAGCAGTT
13q21.1 RP11-100C24 RP11-100C24-A
RP11-100C24-B
RP11-100C24-C
CCACCTCCCAACTCTGTGTGT
CTGCTTTATGGTGCCTTTTGC
TGTTTTGGCTTTCTGGCAGTT
CCCTCCAGAGATAGCACGTTCT
GTCAGAGAGGACTGCGGAAACT
CAAAGGCAGGAGGCTGTTCT
8p22 RP11-89M16 RP11-89M16-A
RP11-89M16-B
RP11-89M16-C
TTCCCAGCTCGTGCTCTCA
TGGATGGTGCTAGAGAGGTAGATG
CAGGATCACCCAAGGCAGTAA
CAGTGGAAGGCTCTTCATGCT
TGCAGGAATGTGCTGGTTTG
TCTAAACTCCCTTTTTGAGGCATTBMC Genomics 2007, 8:167 http://www.biomedcentral.com/1471-2164/8/167
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tion array experiment to detect the number of artifactual
gains/losses. In this latter experiment, no copy number
changes were observed.
The database of human genomic variants [14] was used to
check if the CNV has been previously reported and the
presence of segmental duplications within it. The gene
content strictly within the CNV was established using the
same database as well as the NCBI and UCSC databases
(build 35.1).
FISH
BAC DNA clones that were identified to show copy
number change by array-CGH were purchased from Spec-
tral Genomics (Houston, TX), labeled directly by Spec-
trum Red or Green (Vysis, Downers Grove, IL) using nick
translation and hybridized to metaphase chromosomes
and interphase nuclei from human peripheral blood lym-
phocytes according to the manufacturer's instructions and
as previously published [26]. Slides were viewed on a
Zeiss Axioplan 2 fluorescence microscope and images cap-
tured using Macprobe software (Applied Imaging, Santa
Clara, CA). For each FISH probe, at least 10 metaphase
cells and 50–100 interphase nuclei were counted blindly
by two observers. The normal pattern of FISH signal dis-
tribution was determined using 3 single copy BAC clones
(RP1-3K23 on 7q36.3, RP11-58F7 on 7q36.3 and RP11-
143E20 on Xp22.31), which showed no copy number
changes in any of the control individuals on array analy-
sis. The normal signal counts in 3 control experiments
showed that most of the interphase nuclei had a concord-
ant 1:1 and 2:2 signal pattern, while a discrepant signal
number (mainly 1:2) was seen in around 20% of cells
(due to asynchronous replication and/or FISH artifacts).
This signal pattern is consistent with other publications
using FISH with single copy clones [8].
Based on these values and our experience in FISH confir-
mation of microduplications [24], the predominance of
cells (>50%) with a pattern different than 1:1 or 2:2 was
determined arbitrarily to represent true copy number var-
iability. Increase of DNA clone copy number was consid-
ered if a discrepant number of FISH signals (eg.1:2; 2:3),
or more than 4 signals/interphase nucleus were predomi-
nantly observed (>50 % cells). A loss of the DNA clone
sequences was considered if >50% interphase nuclei/met-
aphase chromosomes had one signal, or one of the signals
was consistently fainter than the other.
RT-qPCR
All array-detected deletions and duplications are con-
firmed using real-time quantitative PCR (RT-qPCR) with
SYBR Green I detection [27], using 3 non-polymorphic
markers evenly distributed within the deleted/duplicated
clones. To ensure optimal primer design, DNA sequences
spanning the target clones were retrieved from on-line
sequence databases and repositories, and checked for the
presence of repeated DNA sequences using RepeatMasker
[28]. This allowed us to identify unique sequences within
the target regions, whilst avoiding DNA segments with
complex repetitive elements. Primer sets were designed
within these unique sequences using the Primer Express v
3.0 program (Applied Biosystems). Primers were checked
for any potential SNPs located within them using online
SNP blasting.
Real-time detection of PCR products was performed using
the ABI Prism 7900HT system which allows one to see the
threshold cycle (CT) during the exponential phase of
amplification (i.e. when none of the PCR reagents are lim-
iting), and quantify each allele, such that a single allele at
a test locus in a person with a deletion would show less
amplification (i.e. ~50%) than in a person with two cop-
ies of that allele. We compared the amplification of test
marker loci (i.e. within the region suspected of being
deleted or duplicated) with that of non-contiguous mark-
ers (i.e. from another chromosomal region) performed at
the same time. The list of primers used is shown in Table
3.
Authors' contributions
YQ conducted the array CGH and FISH experiments for
the majority of cases, analyzed the data and drafted the
manuscript. XL conducted real-time qPCR experiments.
CH conducted FISH experiments, and reviewed the man-
uscript. SN and WTB provided DNA samples and
reviewed the manuscript. MK conducted array CHG exper-
iments and reviewed the manuscript. ERS, SL and JH
designed and supervised the research study, supervised
staff and students, and reviewed the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
This work was supported by grants from the Canadian Institutes for Health 
Research grants (MOP-74502-ERS principal investigator and RT-64217, 
MESL-principal investigator), Vancouver Foundation, a CIHR Interdiscipli-
nary Health Research Team grant (RT-43820) to the Autism Spectrum Dis-
orders Canadian-American Research Consortium [29] (JJAH, principal 
investigator), and a research grant from the Ontario Mental Health Foun-
dation (JJAH, principal investigator); Y. Qiao is a trainee with the CIHR/
NAAR STIHR Inter-Institute Autism Spectrum Disorders Training Program 
(PI:JJAH). E. Rajcan-Separovic is supported by a CIHR Institute of Genetics 
Clinician Investigator Award (2005–09). M.E.S Lewis sincerely appreciates 
the support provided by a Michael Smith Foundation for Health Research 
Career Investigator (Scholar) Award (2005–10).
References
1. Wyandt HE, Tonk VS: Atlas of Human Chromosome Hetero-
morphisms.  , Kluwer Academic Publishers; 2005. 
2. Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, Ghandour
G, Perkins N, Winchester E, Spencer J, Kruglyak L, Stein L, Hsie L,
Topaloglou T, Hubbell E, Robinson E, Mittmann M, Morris MS, Shen
N, Kilburn D, Rioux J, Nusbaum C, Rozen S, Hudson TJ, Lipshutz R,
Chee M, Lander ES: Large-scale identification, mapping, andPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2007, 8:167 http://www.biomedcentral.com/1471-2164/8/167
Page 11 of 11
(page number not for citation purposes)
genotyping of single-nucleotide polymorphisms in the
human genome.  Science 1998, 280:1077-1082.
3. Feuk L, Carson AR, Scherer SW: Structural variation in the
human genome.  Nat Rev Genet 2006, 7:85-97.
4. Carter NP: As normal as normal can be?  Nat Genet 2004,
36:931-932.
5. Freeman JL, Perry GH, Feuk L, Redon R, McCarroll SA, Altshuler DM,
Aburatani H, Jones KW, Tyler-Smith C, Hurles ME, Carter NP,
Scherer SW, Lee C: Copy number variation: new insights in
genome diversity.  Genome Res 2006, 16:949-961.
6. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y,
Scherer SW, Lee C: Detection of large-scale variation in the
human genome.  Nat Genet 2004, 36:949-951.
7. Wong KK, deLeeuw RJ, Dosanjh NS, Kimm LR, Cheng Z, Horsman
DE, MacAulay C, Ng RT, Brown CJ, Eichler EE, Lam WL: A compre-
hensive analysis of common copy-number variations in the
human genome.  Am J Hum Genet 2007, 80:91-104.
8. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S,
Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K,
Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M:
Large-scale copy number polymorphism in the human
genome.  Science 2004, 305:525-528.
9. Hinds DA, Kloek AP, Jen M, Chen X, Frazer KA: Common dele-
tions and SNPs are in linkage disequilibrium in the human
genome.  Nat Genet 2006, 38:82-85.
10. Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK: A
high-resolution survey of deletion polymorphism in the
human genome.  Nat Genet 2006, 38:75-81.
11. McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, Barrett
JC, Dallaire S, Gabriel SB, Lee C, Daly MJ, Altshuler DM: Common
deletion polymorphisms in the human genome.  Nat Genet
2006, 38:86-92.
12. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fie-
gler H, Shapero MH, Carson AR, Chen W, Cho EK, Dallaire S, Free-
man JL, Gonzalez JR, Gratacos M, Huang J, Kalaitzopoulos D, Komura
D, MacDonald JR, Marshall CR, Mei R, Montgomery L, Nishimura K,
Okamura K, Shen F, Somerville MJ, Tchinda J, Valsesia A, Woodwark
C, Yang F, Zhang J, Zerjal T, Armengol L, Conrad DF, Estivill X, Tyler-
Smith C, Carter NP, Aburatani H, Lee C, Jones KW, Scherer SW,
Hurles ME: Global variation in copy number in the human
genome.  Nature 2006, 444:444-454.
13. Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VA, Pertz LM, Haugen
E, Hayden H, Albertson D, Pinkel D, Olson MV, Eichler EE: Fine-
scale structural variation of the human genome.  Nat Genet
2005, 37:727-732.
14. Database of Genomic Variants    [http://projects.tcag.ca/varia
tion/]
15. Eichler EE: Widening the spectrum of human genetic varia-
tion.  Nat Genet 2006, 38:9-11.
16. eFISH   [http://projects.tcag.ca/efish/]
17. Schoumans J, Ruivenkamp C, Holmberg E, Kyllerman M, Anderlid BM,
Nordenskjold M: Detection of chromosomal imbalances in
children with idiopathic mental retardation by array based
comparative genomic hybridisation (array-CGH).  J Med Genet
2005, 42:699-705.
18. Schoumans J, Nordgren A, Ruivenkamp C, Brondum-Nielsen K, Teh
BT, Anneren G, Holmberg E, Nordenskjold M, Anderlid BM:
Genome-wide screening using array-CGH does not reveal
microdeletions/microduplications in children with Kabuki
syndrome.  Eur J Hum Genet 2005, 13:260-263.
19. Lapierre JM, Sanlaville D, Kang J, Ozilou C, Le Lorc'h M, Waill MC,
Prieur M, Colleaux L, Munnich A, Turleau C, Benkhalifa M, Moham-
med M, Vekemans M, Romana S: A preliminary study to assess
the value of the DNA chips SpectralChip to detect subtle
constitutional chromosome imbalances.  Ann Biol Clin (Paris)
2004, 62:203-212.
20. de Vries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, Janssen IM,
Reijmersdal S, Nillesen WM, Huys EH, Leeuw N, Smeets D, Sister-
mans EA, Feuth T, van Ravenswaaij-Arts CM, van Kessel AG, Schoen-
makers EF, Brunner HG, Veltman JA: Diagnostic genome profiling
in mental retardation.  Am J Hum Genet 2005, 77:606-616.
21. Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, Vallente RU,
Pertz LM, Clark RA, Schwartz S, Segraves R, Oseroff VV, Albertson
DG, Pinkel D, Eichler EE: Segmental duplications and copy-
number variation in the human genome.  Am J Hum Genet 2005,
77:78-88.
22. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G,
Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin
BH, Bradley W, Clark RA, Anderson SA, O'Connell R J, Agan BK,
Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK: The influence of
CCL3L1 gene-containing segmental duplications on HIV-1/
AIDS susceptibility.  Science 2005, 307:1434-1440.
23. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J,
Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD,
Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ,
Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT: Copy number poly-
morphism in Fcgr3 predisposes to glomerulonephritis in rats
and humans.  Nature 2006, 439:851-855.
24. Tyson C, Harvard C, Locker R, Friedman JM, Langlois S, Lewis ME,
Van Allen M, Somerville M, Arbour L, Clarke L, McGilivray B, Yong
SL, Siegel-Bartel J, Rajcan-Separovic E: Submicroscopic deletions
and duplications in individuals with intellectual disability
detected by array-CGH.  Am J Med Genet A 2005, 139:173-185.
25. DECIPHER   [http://www.sanger.ac.uk/PostGenomics/decipher/]
26. Rajcan-Separovic E, Mahadevan MS, Lefebvre C, Besner-Johnston A,
Ikeda JE, Korneluk RG, MacKenzie A: FISH detection of chromo-
some polymorphism and deletions in the spinal muscular
atrophy (SMA) region of 5q13.  Cytogenet Cell Genet 1996,
75:243-247.
27. Weksberg R, Hughes S, Moldovan L, Bassett AS, Chow EW, Squire
JA: A method for accurate detection of genomic microdele-
tions using real-time quantitative PCR.  BMC Genomics 2005,
6:180.
28. RepeatMasker    [http://repeatmasker.com]
29. ASD-CARC   [http://www.autismresearch.ca]